Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis

As indicators of responsiveness to a tumour necrosis factor (TNF)α blocking agent (infliximab) are lacking in rheumatoid arthritis, we have used gene profiling in peripheral blood mononuclear cells to predict a good versus poor response to infliximab. Thirty three patients with very active disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Lequerré, Thierry, Gauthier-Jauneau, Anne-Christine, Bansard, Carine, Derambure, Céline, Hiron, Martine, Vittecoq, Olivier, Daveau, Maryvonne, Mejjad, Othmane, Daragon, Alain, Tron, François, Le Loët, Xavier, Salier, Jean-Philippe
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779405/
https://www.ncbi.nlm.nih.gov/pubmed/16817978
http://dx.doi.org/10.1186/ar1990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779405/
https://www.ncbi.nlm.nih.gov/pubmed/16817978
http://dx.doi.org/10.1186/ar1990

Ejemplares similares